Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Arquivos Brasileiros De Endocrinologia E Metabologia|April 15, 2014
Response to sorafenib treatment in advanced metastatic thyroid cancerFabian PitoiaEndocrine-Related Cancer|January 28, 2014
Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response?Fabian PitoiaThyroid Research|March 13, 2023
Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experienceAnabella Smulever, Fabian PitoiaReviews in Endocrine & Metabolic Disorders|December 2, 2023
New insights in thyroid diagnosis and treatmentFabian Pitoia, Pierpaolo TrimboliEndocrine-Related Cancer|August 9, 2019
Dynamic risk assessment in patients with differentiated thyroid cancerFabian Pitoia, Fernando JerkovichWorld Journal of Clinical Oncology|September 3, 2020
Active surveillance in low risk papillary thyroid carcinomaFabian Pitoia, Anabella SmuleverReviews in Endocrine & Metabolic Disorders|October 13, 2023
Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directionsAnabella Smulever, Fabian PitoiaEndocrine|May 27, 2024
Primary resistance to selpercatinib in a patient with advanced medullary thyroid cancerFabian Pitoia, Pierpaolo Trimboli, Erika AbelleiraEndocrine|September 23, 2016
Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSHFabian Pitoia, Erika Abelleira, Graciela CrossReviews in Endocrine & Metabolic Disorders|August 30, 2023
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable diseaseInés Califano, Anabella Smulever, Fernando Jerkovich, et al.Pageof 4